Goldman Sachs’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.11M Buy
783,220
+352,546
+82% +$979K ﹤0.01% 4493
2025
Q4
$943K Buy
430,674
+158,078
+58% +$392K ﹤0.01% 5187
2025
Q3
$638K Sell
272,596
-80,711
-23% -$138K ﹤0.01% 5353
2025
Q2
$537K Buy
353,307
+22,766
+7% +$35.5K ﹤0.01% 5117
2025
Q1
$458K Sell
330,541
-180,974
-35% -$386K ﹤0.01% 5240
2024
Q4
$1.16M Buy
511,515
+190,156
+59% +$668K ﹤0.01% 4705
2024
Q3
$1.52M Sell
321,359
-74,464
-19% -$431K ﹤0.01% 4369
2024
Q2
$2.96M Sell
395,823
-29,351
-7% -$360K ﹤0.01% 3623
2024
Q1
$7.25M Buy
425,174
+187,037
+79% +$4.01M ﹤0.01% 2766
2023
Q4
$5.41M Sell
238,137
-61,915
-21% -$1.04M ﹤0.01% 3089
2023
Q3
$4.57M Buy
+300,052
New +$4.1M ﹤0.01% 3063
2023
Q2
Sell
-161,596
Closed -$1.34M 5774
2023
Q1
$1.34M Buy
+161,596
New +$1.51M ﹤0.01% 4172
2022
Q4
Sell
-10,996
Closed -$7K 5998
2022
Q3
$7K Sell
10,996
-2,949
-21% -$3.55K ﹤0.01% 6057
2022
Q2
$15K Buy
13,945
+86
+0.6% +$122 ﹤0.01% 6216
2022
Q1
$28K Buy
13,859
+685
+5% +$1.79K ﹤0.01% 6365
2021
Q4
$50K Sell
13,174
-29,793
-69% -$318K ﹤0.01% 6267
2021
Q3
$522K Buy
42,967
+7,594
+21% +$70K ﹤0.01% 5167
2021
Q2
$304K Sell
35,373
-9,514
-21% -$93.5K ﹤0.01% 5515
2021
Q1
$498K Buy
44,887
+13,407
+43% +$164K ﹤0.01% 5125
2020
Q4
$393K Buy
31,480
+6,411
+26% +$83.2K ﹤0.01% 4750
2020
Q3
$272K Sell
25,069
-3,531
-12% -$40.6K ﹤0.01% 4782
2020
Q2
$319K Buy
28,600
+3,297
+13% +$25.2K ﹤0.01% 4593
2020
Q1
$185K Buy
+25,303
New +$347K ﹤0.01% 4733

Other funds holding CABA